Glycerol tight market business investment continued to rise
ACI expects healthcare antiseptic manufacturers to lose most active ingredients
The US Food and Drug Administration (FDA) will ban some 80% of active ingredients currently allowed for use in healthcare antiseptics, the American Cleaning Institute (ACI) expects.
Plans to require manufacturers to submit data demonstrating the safety and efficacy of their antibacterial ingredients were set out in a 2015 proposed rule - and are expected to become law when the final rule is issued. The FDA will assess data submitted by industry and decide whether to classify actives as "generally recognised as safe and effective" (Gras/Grae), or ban their use in the products.
ACI expects triclosan to face a ban in healthcare products as well, along with more than 20 other ingredients, its associate vice president for environmental safety, Paul DeLeo, told CW+BiocidesHub.
Some substances will be banned due to a lack of support by industry, he said. "Companies know it won't get FDA approval so they are not willing to do the additional testing the agency is requiring."
Others will fail because the data to support them is too challenging to generate. The agency, he says, is asking for "new methods that we are not aware of anyone having successfully completed in this space", but it has been willing to give companies more time.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
2026-06-19
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Is Glycerol Water Soluble? An Oddball Solution For Hydration
-
Market Analysis - Weekly Report - February 14th to February 18th, 2022- Hot Products
-
Market Analysis- Weekly Report- November 1st to November 5th, 2021- Hot Products
-
BASF sends out a price increase letter again! MDI, glycerol, epoxy and many other raw materials have soared!
-
Eurofragance Opens New Creative Center in Jakarta to Expand Its Asian Footprint
-
Givaudan to Build New Fragrance Compounding Facility in Pedro Escobedo, Mexico
-
Procter & Gamble Posts Higher Profits on Strong Personal Care Sales and Recovery in China
-
Univar Solutions Expands EMEA Portfolio Through Exclusive Distribution Agreement with CABB Group
-
Rising Naphtha Prices in Japan Drive Up Costs for Diapers, Sanitary Products, and Cosmetics
-
Blackstone in Talks to Buy Juno Hair in South Korea for $590 Million
Recommend Reading
-
Eurofragance Launches Proprietary Fragrance Ingredient Olivante
-
L Catterton to Acquire Minority Stake in Perfume Company EX NIHILO
-
Suave Brands and Elida Beauty Complete Merger to Form Personal Care Giant Evermark with Annual Retail Sales Near $1.9 Billion
-
Azelis Partners with Sharon Personal Care in Colombia, Peru and Ecuador
-
BASF and Hannong Chemical Joint Venture Nonionic Surfactant Plant Begins Operation in South Korea
-
UAE Breaks Ground on World’s First Gigascale Round-the-Clock Renewable Energy Project, Setting a New Global Standard For Clean Energy
-
October Adipic Acid Market Weakens and Falls
-
Cost Decline, Weak Demand—Oxynol Prices Fluctuate and Fall This Week
-
Evonik Releases Financial Results Statement and Expects No Recovery in Global Chemical Market Demand in 2026
-
This week, the cyclohexane market in China mainly maintained a stable operation (10.20-10.27)